Anti-ACADS/SCAD antibody [EPR10862(B)]
- RabMAb
- Recombinant
- What is this?
5
(2 Reviews)
|
(7 Publications)
Rabbit Recombinant Monoclonal ACADS/SCAD antibody. Suitable for IHC-P, IP, WB and reacts with Human, Rat, Mouse samples. Cited in 7 publications.
View Alternative Names
SCAD, Butyryl-CoA dehydrogenase, ACADS
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACADS/SCAD antibody [EPR10862(B)] (AB156571)
ab156571 showing +ve staining in Human gastric adenocarcinoma.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACADS/SCAD antibody [EPR10862(B)] (AB156571)
ab156571 showing +ve staining in Human urinary bladder carcinoma.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACADS/SCAD antibody [EPR10862(B)] (AB156571)
ab156571 showing +ve staining in Human normal liver.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACADS/SCAD antibody [EPR10862(B)] (AB156571)
Immunohistochemical analysis of paraffin embedded Human thyroid gland tissue labeling ACADS/SCAD with ab156571 antibody at 1/50.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACADS/SCAD antibody [EPR10862(B)] (AB156571)
ab156571 showing +ve staining in Human normal colon.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACADS/SCAD antibody [EPR10862(B)] (AB156571)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human hepatocellular carcinoma tissue sections labeling ACADS/SCAD with Purified ab156571 at 1 : 100 dilution (3.76 µg/ml). Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). Purified)ImmunoHistoProbe one step HRP Polymer (ready to use) was used for detection. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACADS/SCAD antibody [EPR10862(B)] (AB156571)
Immunohistochemical analysis of paraffin embedded Human heart tissue labeling ACADS/SCAD with ab156571 antibody at 1/50.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IP
Unknown
Immunoprecipitation - Anti-ACADS/SCAD antibody [EPR10862(B)] (AB156571)
ab156571 (Purified) at 1 : 20 dilution (2 µg) immunoprecipitating ACADS/SCAD in Human liver lysate.
Lane 1 (input) : Human liver lysate 10 µg
Lane 2 (+) : ab156571 & Human liver lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab156571 in Human liver lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab156571)
All lanes:
Immunoprecipitation - Anti-ACADS/SCAD antibody [EPR10862(B)] (ab156571)
Predicted band size: 44 kDa
false
- WB
Lab
Western blot - Anti-ACADS/SCAD antibody [EPR10862(B)] (AB156571)
All lanes:
Western blot - Anti-ACADS/SCAD antibody [EPR10862(B)] (ab156571) at 1/1000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 20 µg
Lane 2:
Mouse liver lysates at 20 µg
Lane 3:
Rat kidney lysates at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 44 kDa
Observed band size: 41 kDa
false
Related conjugates and formulations (1)
-
Anti-ACADS/SCAD antibody [EPR10862(B)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The function of ACADS involves the conversion of fatty acids into acetyl-CoA an essential step in energy production. ACADS operates in concert with other enzymes in the mitochondrial matrix contributing to the beta-oxidation cycle. This enzyme is essential for maintaining energy homeostasis particularly during periods of fasting or increased energy demands. Although ACADS is not a component of a larger enzyme complex it works closely with other dehydrogenases that metabolize different chain lengths of fatty acids.
Pathways
The ACADS enzyme is critically involved in the fatty acid beta-oxidation pathway. This pathway is vital for energy production especially in cardiac and skeletal muscles. ACADS is functionally related to other enzymes such as MCAD (medium-chain acyl-CoA dehydrogenase) and VLCAD (very long-chain acyl-CoA dehydrogenase) through the sequential processing of fatty acids of varying chain lengths. Proper functioning of the beta-oxidation pathway ensures that fatty acids are systematically broken down to meet the body’s energetic needs.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Animal cells and systems 29:512-522 PubMed40800577
2025
Applications
Unspecified application
Species
Unspecified reactive species
Aging cell 23:e14256 PubMed38898632
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular neuroscience 15:1064509 PubMed36743291
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 79:375 PubMed35727412
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cancer prevention 26:32-40 PubMed33842404
2021
Applications
Unspecified application
Species
Unspecified reactive species
Biochemical pharmacology 178:114100 PubMed32540485
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 20:1381-91 PubMed26989860
2016
Applications
WB
Species
Rat
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com